Osteoarthritis Burden Increasing Among Postmenopausal Women

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 5, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 5, 2025 -- The burden of osteoarthritis (OA) is increasing among postmenopausal women, according to a study published online March 4 in BMJ Global Health.

Huadong Xu, from Hangzhou Medical College in the People's Republic of China, and colleagues used data from the Global Burden of Disease Study in 2021 to examine global burden and temporal trends in the incidence, prevalence, and disability-adjusted life-years (DALYs) of OA among postmenopausal women from 1990 to 2021. Subtypes of OA affecting the hip, knee, hand, and other joints were included.

The researchers observed more than 1.3-fold increases in OA incidence, prevalence, and DALYs among postmenopausal women globally from 1990 to 2021, with estimated annual percentage changes of 0.211, 0.356, and 0.395, respectively. The heaviest burden was seen for knee OA, while hip OA bore the lowest burden. A higher burden was seen in higher sociodemographic index (SDI) regions; over time, inequalities linked to SDI intensified. The most substantial increments in OA burden were seen in East Asia and high-income Asia Pacific. High body mass index (BMI) had a significant influence on OA burden, especially in countries within high, high-middle, and middle SDI, where DALYs due to high BMI exceeded 20 percent.

"High SDI countries face a disproportionate OA burden, with widening SDI-related inequalities among nations over time," the authors write. "This underscores the urgent need for targeted interventions and rigorous health strategies to control and manage OA, focusing on modifiable risk factor reduction."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-06 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords